Brief: Oasmia Pharmaceutical Q4 Operating Loss Narrows To SEK 2.1 Mln
24/02/2022 07:22
Feb 24 (Reuters) - Oasmia Pharmaceutical AB OASM.ST :
* YEAR-END REPORT JANUARY 1, 2021 – DECEMBER 31, 2021
* Q4 CONSOLIDATED NET SALES AMOUNTED TO TSEK 9,639 (131)
* Q4 OPERATING LOSS TSEK 2,068 (-59,441)
Source text for Eikon: ID:nMFN9FdRXq
Further company coverage: OASM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))